Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0218290 CAMEL DERIVED POLYPEPTIDES BINDING HUMAN CD3, IDENTIFIED USING A NOVEL ONE-STEP METHOD
The present invention relates to variable domains of camelid heavy-chain antibodies (VHH domains) directed against the human CD3.epsilon. component of the T...
2019/0218289 METHODS FOR ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS
Methods are provided for treating a subject with a therapeutic dose of anti-CD47 agent by administering a primer agent prior to administering a therapeutically...
2019/0218288 FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
The present invention relates to antibodies or fragments thereof that specifically bind Fc.gamma.RIIB, particularly human Fc.gamma.RIIB, with greater affinity...
2019/0218287 TRPM4 CHANNEL INHIBITORS FOR STROKE TREATMENT
The present invention relates to methods for treating ischemic stroke including extension of the therapeutic time window for reperfusion. More particularly,...
2019/0218286 COMPOSITIONS AND METHODS FOR MEASURING NMU AND FOR TREATMENT USING ANTI-NMU AGENTS
The inventors have produced two high specificity and high affinity monoclonal antibodies that bind to human neuromedin U (NMU). Methods and compositions are...
2019/0218285 Long-Acting Therapeutic Fusion Proteins
Chimeric Fc fusion polypeptides are provided, optionally including biologically active polypeptides for therapeutic use.
2019/0218284 METHODS OF TREATING EOSINOPHILIC GASTROINTESTINAL DISEASES
Methods of treating or preventing Eosinophilic Gastrointestinal Diseases (EGIDs), including eosinophilic esophagitis (EOE) by administering anti-GM-CSF...
2019/0218283 METHODS FOR INHIBITING MYOSTATIN ACTIVATION BY ADMINISTERING ANTI-PRO/LATENT MYOSTATIN ANTIBODIES
The present invention relates to antibodies that specifically bind pro-myostatin and/or latent myostatin, and methods and uses thereof.
2019/0218282 NOVEL ANTIBODY FORMAT
Herein is reported a recombinant fusion polypeptide comprising an antibody heavy chain variable domain, a multimerization domain and an antibody light chain...
2019/0218281 TREATMENT OF TAUOPATHIES
The invention is directed to methods of treatment of Alzheimer's disease and other tauopathies, via the administration of antibodies having specificity to...
2019/0218280 Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy
Chimeric antigen receptors containing mesothelin antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen...
2019/0218279 PAC1 ANTIBODIES AND USES THEREOF
The present invention relates to neutralizing antibodies of the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) and...
2019/0218278 A METHOD FOR TREATING AGE-RELATED MACULAR DEGENERATION IN A PATIENT
The present disclosure relates to, inter alia, a method of treating age-related macular degeneration (AMD) in a patient, comprising administering an effective...
2019/0218277 ANTI-DENGUE VIRUS ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE
The disclosure provides anti-DENV antibodies and methods of making and using the same. Nucleic acids encoding anti-DENV antibodies and host cells comprising...
2019/0218276 METHODS FOR DETERMINING SPATIAL AND TEMPORAL GENE EXPRESSION DYNAMICS IN SINGLE CELLS
Transcriptomes of individual neurons provide rich information about cell types and dynamic states. However, it is difficult to capture rare dynamic processes,...
2019/0218275 IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are...
2019/0218274 ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
The present disclosure provides pharmaceutical formulations for sustained release, and methods for delivering a treatment regimen with a combination of...
2019/0218273 ANGIOPOIETIN-2 SPECIFIC TIE2 RECEPTOR
In one aspect, provided herein is a polypeptide comprising a modified angiopoietin receptor or fragment thereof, wherein the polypeptide binds preferentially...
2019/0218272 ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF
In certain aspects, the disclosure provides soluble heteromeric polypeptide complexes comprising an extracellular domain of an ALK4 receptor and an...
2019/0218271 MUTANT LIGHT-INDUCIBLE ION CHANNEL OF CHRIMSON
The invention relates to mutant light-inducible ion channels having improved properties as compared to the parent channel, nucleic acid constructs encoding...
2019/0218270 GIP-GLP-1 DUAL AGONIST COMPOUNDS AND METHODS
The present invention relates to acylated GIP analogues which have dual GIP and GLP-1 activity, and their use in the treatment of metabolic disorders.
2019/0218269 TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST
A a triple agonist having activities to all of glucagon, GLP-1, and GIP receptors is disclosed. Uses of the triple agonist are disclosed.
2019/0218268 AQUEOUSLY SOLUBLE & CHEMICALLY STABLE GLUCAGON PEPTIDES
Modified glucagon peptides are disclosed having improved solubility and/or stability while retaining glucagon agonist activity. The glucagon peptides have been...
2019/0218267 IL-21 (HETERODIMERIC FC-FUSED IL-21) FUSED TO IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION HETERODIMER...
A heterodimeric Fc-fused protein and a pharmaceutical composition comprising the heterodimeric Fc-fused protein are disclosed. The heterodimeric Fc-fused...
2019/0218266 FUSION PROTEIN COMPRISING ANTIFREEZE PROTEIN AND HUMAN EPIDERMAL GROWTH FACTOR WITH INCREASED ANTI-OXIDANT...
A fusion protein has the amino acid sequence of SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8. A composition having the fusion protein may improve...
2019/0218265 Novel Ligand and Use Thereof
The present invention is within the field of protein engineering and purification. The invention relates to a target-binding polypeptide mutant of an IgG...
2019/0218264 TARGETED EFFECTOR PROTEINS AND USES THEREOF
Provided herein are targeted effector fusion proteins, complexes thereof, and uses thereof. The targeted effector fusion proteins can include an effector...
2019/0218263 NORRIN REGULATION OF CELLULAR PRODUCTION OF JUNCTION PROTEINS AND USE TO TREAT RETINAL VASCULATURE EDEMA
A method of tightening inter-cellular junctions in retinal or choroidal vessel cells includes exposing the retinal or choroidal vessel cells to norrin and an...
2019/0218261 TARGETED ENHANCED DNA DEMETHYLATION
Provided herein are, inter alia, compositions and methods for the delivery of enhanced demethylation activity to target DNA sequences in a mammalian cell. The...
2019/0218260 COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOGENIC CROSS-PRESENTATION OF TUMOR ANTIGENS
Cell loss by apoptosis is a common feature in certain conditions, including cancer. Dying tumor cells induce immune tolerance within the tumor microenvironment...
2019/0218259 COMPOSITIONS AND METHODS FOR BROWN FAT INDUCTION AND ACTIVITY USING FNDC5
The invention provides compositions and methods for brown fat induction and activity through modulation of Fndc5 activity and/or expression. Also provided are...
2019/0218258 Compositions And Related Methods For Modulating Alkaloid Production By Controlling PMT Promoter Activation...
Compositions and methods for modifying the production levels of alkaloids in plants are provided. Alkaloid production can be genetically controlled by...
2019/0218257 NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF
Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from...
2019/0218256 MUTANT LIGHT-INDUCIBLE ION CHANNEL OF CHANNELRHODOPSIN
The invention relates to mutant light-inducible ion channel having improved properties as compared to the parent channel, nucleic acid constructs encoding...
2019/0218255 SCN9A ANTISENSE OLIGONUCLEOTIDES
The current invention provides peptide nucleic acid derivatives targeting a part of the human SCN9A pre-mRNA. The peptide nucleic acid derivatives potently...
2019/0218254 IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition containing a population of...
2019/0218253 Therapeutic SALL4 Peptide
The present invention provides, in certain embodiments, isolated peptides and pharmaceutical compositions comprising isolated peptides that bind to ...
2019/0218252 1,2,4-Oxadiazole Compounds as Inhibitors of CD47 Signalling
The present invention relates to compounds of formula (I), compositions, methods and uses involving the said formula (I) that inhibit CD47 signaling pathway....
2019/0218251 DEUTERATED COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCERS ASSOCIATED WITH ETBR ACTIVATION
Disclosed herein are deuterated compounds, pharmaceutical compositions thereof, and methods for treating ETBR-related cancers. Also disclosed herein is a...
2019/0218250 METHODS OF REDUCING LEVEL OF ONE OR MORE IMPURITIES IN A SAMPLE DURING PROTEIN PURIFICATION
The present invention provides novel and improved protein purification processes which incorporate certain types of carbonaceous materials and result in...
2019/0218249 A PROCESS FOR PURIFICATION OF CARFILZOMIB INTERMEDIATE
The present invention relates to a process for the purification of compound of formula II, wherein X may be independently selected from trifluoroacetic acid,...
2019/0218248 METHODS OF PURIFYING PROTEINS
In some embodiments, the present invention provides a method of purifying a protein of interest with a reduced level of aggregation formation in cation...
2019/0218247 METHODS AND SYSTEMS FOR PROTEIN REFOLDING
The invention provides methods and systems for production of recombinant protein, and particularly, for production of recombinant protein from inclusion...
2019/0218246 INHIBITORS OF GLUCOCORTICOID RECEPTOR
The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal...
2019/0218245 COMPOUNDS AND METHODS INVOLVING STEROLS
Compounds and methods of synthesizing oxysterols are provided. The compounds and methods provided allow the oxysterol to be safely produced at a high yield....
2019/0218244 ANTISENSE NUCLEIC ACIDS
The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a...
2019/0218243 IMPROVED PROCESSES FOR THE PREPARATION OF SOFOSBUVIR AND INTERMEDIATES THEREOF
The present disclosure provides procedures and intermediates for the preparation of Sofosbuvir, comprising the step of reacting a compound of formula 2:...
2019/0218242 METHOD OF COALESCING A SUBSTANCE
Provided is a method of coalescing a substance comprising providing a first mixture comprising a substance, agitating at least a portion of the first mixture...
2019/0218241 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex...
2019/0218240 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND ORGANIC...
Provided are an organometallic compound, an organic light-emitting device including the organometallic compound represented by Formula 1, and an organic...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.